Article info
PDFHeart rhythm disorders
Original article
Risk stratification schemes, anticoagulation use and outcomes: the risk–treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation
- Correspondence to Dr Roopinder K Sandhu, University of Alberta, 2C2. 30z WMC, 8440-112 Street, Edmonton, Alberta T6G 2B7, Canada; rsandhu2{at}ualberta.ca
Citation
Risk stratification schemes, anticoagulation use and outcomes: the risk–treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation
Publication history
- Accepted September 28, 2011
- First published November 10, 2011.
Online issue publication
March 15, 2016
Article Versions
- Previous version (15 March 2016).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data Supplement - Manuscript file of format pdf
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.